Huberta A. T. Dekker

Author

Also Known As

H A Dekker, H.A.T. Dekker, H.A.Th. Dekker, Huberta A T Dekker, Huberta A Th Dekker, Huberta A. T. Dekker, Huberta A. Th. Dekker, Huberta A.Th. Dekker

Publications

559

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University University College Dublin St. Antonius Ziekenhuis

About

Huberta A. T. Dekker is an author at University Medical Center Utrecht specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	51
2	Immunology	3	3	51
3	Allergy	1	1	15
4	Microbiology	1	1	13
5	Autoimmune Disease	1	1	15

Huberta A. T. Dekker

Publications

544

Citations

H-Index

Page 1

	Year	Citations
Gold Nanoparticles as Carriers for A Synthetic <i>Streptococcus Pneumoniae</i> Type 14 Conjugate Vaccine Dodi Safari, Marco Marradi, Fabrizio Chiodo, Nanomedicine	2012	168
Identification of the Smallest Structure Capable of Evoking Opsonophagocytic Antibodies against <i>Streptococcus pneumoniae</i> Type 14 Dodi Safari, Huberta A. T. Dekker, John Joosten, Infection and Immunity	2008	105
Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG Elsa Velasco, A F Verheul, A M van Steijn, Infection and Immunity	1994	54
Hospital and Community Ampicillin-Resistant Enterococcus faecium Are Evolutionarily Closely Linked but Have Diversified through Niche Adaptation Marieke J. A. de Regt, Willem van Schaik, Miranda van Luit‐Asbroek, PLoS ONE	2012	52
Potent Inhibition of Neutrophil Migration by Cryptococcal Mannoprotein-4-Induced Desensitization Frank E. J. Coenjaerts, Annemiek Walenkamp, Pauline N. M. Mwinzi, The Journal of Immunology	2001	52
Cytomegalovirus Seroprevalence as a Risk Factor for Poor Outcome in Acute Respiratory Distress Syndrome* David S. Y. Ong, Peter M. C. Klein Klouwenberg, Frans M. Verduyn Lunel, Critical Care Medicine	2014	38
Biocompatibility of a 1.1 &percnt; Amino Acid-Containing Peritoneal Dialysis Fluid Compared to a 2.27&percnt; Glucose-Based Peritoneal Dialysis Fluid Harald F. H. Brulez, Huberta A. T. Dekker, P. L. Oe, Nephron	1996	24
Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines Elsa Velasco, Huberta A. T. Dekker, Péter Antal, Vaccine VaccinationInflammationCross-protectionVaccinologyAdjuvant Quil A	1994	23
Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates Dodi Safari, Huberta A. T. Dekker, Ger T. Rijkers, Vaccine AllergyAutoimmune DiseasePrimary Immunization SiteRobust Immune ResponseImmunology	2010	15
Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies A F Verheul, Anneke Kuipers, A. Koen Braat, Clinical and Diagnostic Laboratory Immunology Laboratory ImmunologyImmunologyBiological PropertiesImmunotherapy,9-Specific Monoclonal Antibodies	1994	13

Page 1